Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.
Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.
Dr. Laura Ajram, Psychiatry Consortium Programme Manager at Medicines Discovery Catapult (MDC) has landed the prestigious ELRIG Early Career Impact Award 2021.
Medicines Discovery Catapult (MDC) today announces the reappointment of Prof. Chris Molloy as CEO from January 2022.
Medicines Discovery Catapult (MDC) today announces the reappointment of experienced scientist and investor Dr Robin Brown, as Chairman.
In this workshop, we explored the evolving landscape of hearing therapeutics and the role of collaboration in advancing the field.
Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting an innovative funding model aimed at opening new funding opportunities for early-stage medicines discovery.
The facility, which was closed in 2020, includes the multi-million pound cyclotron, one of only a handful in the UK.
A new wave of medicines has emerged in recent years, to supplement the established small and large molecule platforms. These complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds.
The BioIndustry Association (BIA), the Wellcome Sanger Institute and Medicines Discovery Catapult (MDC) have today launched Genomics Nation.
The Catapult Network is ready to play a key role in implementing the strategy and supporting industrial sectors to innovate.
See how we can help support you with your next drug discovery project.
Speak to us
